<DOC>
	<DOCNO>NCT02495272</DOCNO>
	<brief_summary>The investigator plan determine effect time oxytocin administration amount blood loss , necessity additional medical surgical intervention .</brief_summary>
	<brief_title>Postpartum Uterotonic Administration</brief_title>
	<detailed_description>The investigator study effect time intramuscular oxytocin administration third stage labour . The investigator measure postpartum blood loss : quantitatively postpartum 1st hour indirectly decrease hemoglobin-haematocrit level postpartum 24th hour . The investigator monitor length third stage labour , need extra uterotonics and/or surgical intervention .</detailed_description>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Cephalic presentation Singleton pregnancy Gestational age &gt; 35 week , In active labour . Expected fetal birth weight 25004500 gram . Acute Fetal Distress Conversion abdominal delivery Persistent high blood pressure ( &gt; 140/90mmHg ) Placenta Previa Ablatio placenta Previous CSection Uterine scar Postpartum hemorrhage previous pregnancy . Hydramnios Maternal infection Forceps/Vacuum Assisted delivery Abnormal placentation ( Placenta accreta , increta percreta ) Coagulation Defects Hemoglobin &lt; 8g/dl</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>Third stage labour</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Uterotonics</keyword>
	<keyword>Active management third stage labour</keyword>
</DOC>